Figure 1From: Active immunotherapy options for Alzheimer’s diseaseImmunotherapy approach to beta-amyloid clearance. Aβ, amyloid-beta protein; BBB, blood–brain barrier; CNS, central nervous system; mAb, monoclonal antibody.Back to article page